SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences touches roof on re-commencing trial production at Dahej manufacturing unit

26 Jun 2020 Evaluate

Camlin Fine Sciences is locked at upper circuit limit Rs. 53.35, up by 4.85 points or 10.00% from its previous closing of Rs. 48.50 on the BSE.

The scrip opened at Rs. 53.35 and has touched a high and low of Rs. 53.35 and Rs. 53.00 respectively. So far 15714 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 89.90 on 02-Jan-2020 and a 52 week low of Rs. 33.40 on 25-Mar-2020.

Last one week high and low of the scrip stood at Rs. 53.35 and Rs. 46.05 respectively. The current market cap of the company is Rs. 646.89 crore.

The promoters holding in the company stood at 22.74%, while Institutions and Non-Institutions held 22.27% and 54.99% respectively.

Camlin Fine Sciences has re?commenced trial production at its manufacturing unit located at Dahej on June 25, 2020. The company had shut?down its manufacturing unit at Dahej which was severely affected due to massive explosion in the adjoining unit belonging to Yashashvi Rasayan Private on June 3, 2020. The company was conducting trial production at the said unit.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).


Camlin Fine Sciences Share Price

132.30 -4.05 (-2.97%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×